Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Eukaryotic elongation factor 2 controls TNF-α translation in LPS-induced hepatitis
Bárbara González-Terán, … , Roger J. Davis, Guadalupe Sabio
Bárbara González-Terán, … , Roger J. Davis, Guadalupe Sabio
Published December 3, 2012
Citation Information: J Clin Invest. 2013;123(1):164-178. https://doi.org/10.1172/JCI65124.
View: Text | PDF | Corrigendum
Research Article Inflammation

Eukaryotic elongation factor 2 controls TNF-α translation in LPS-induced hepatitis

  • Text
  • PDF
Abstract

Bacterial LPS (endotoxin) has been implicated in the pathogenesis of acute liver disease through its induction of the proinflammatory cytokine TNF-α. TNF-α is a key determinant of the outcome in a well-established mouse model of acute liver failure during septic shock. One possible mechanism for regulating TNF-α expression is through the control of protein elongation during translation, which would allow rapid cell adaptation to physiological changes. However, the regulation of translational elongation is poorly understood. We found that expression of p38γ/δ MAPK proteins is required for the elongation of nascent TNF-α protein in macrophages. The MKK3/6-p38γ/δ pathway mediated an inhibitory phosphorylation of eukaryotic elongation factor 2 (eEF2) kinase, which in turn promoted eEF2 activation (dephosphorylation) and subsequent TNF-α elongation. These results identify a new signaling pathway that regulates TNF-α production in LPS-induced liver damage and suggest potential cell-specific therapeutic targets for liver diseases in which TNF-α production is involved.

Authors

Bárbara González-Terán, José R. Cortés, Elisa Manieri, Nuria Matesanz, Ángeles Verdugo, María E. Rodríguez, Águeda González-Rodríguez, Ángela Valverde, Pilar Martín, Roger J. Davis, Guadalupe Sabio

×

Figure 5

p38γ/δLyz-KO mice are protected against LPS-induced liver damage. p38γLyz-KO, p38δLyz-KO, p38γ/δLyz-KO, and control Lyzs-cre transgenic mice were injected with D-gal+LPS or saline.

Options: View larger image (or click on image) Download as PowerPoint
p38γ/δLyz-KO mice are protected against LPS-induced liver damage. p38γLy...
(A) Mouse survival after D-gal+LPS injection (n = 14). Survival curves were created with the Kaplan-Meier method and compared by log-rank (Mantel-Cox) test. (B) Livers were removed at 6 hours after injection. Panels show representative H&E-stained liver sections and livers (n = 5–8). Scale bar: 50 μm. (C) Hemorrhagic area as a percentage of the total area on H&E-stained liver sections (n = 5–8). (D) Immunoblot analysis of liver extracts (n = 5–8). (E) Serum transaminase activity at 6 hours after injection (n = 8–10). (F) ELISA of serum TNF-α and IL-6 at different times after injection (n = 10). #P < 0.01 for Lyzs-cre versus p38δLyz-KO mice in TNF-α; *P < 0.001 for Lyzs-cre versus p38γ/δLyz-KO mice for TNF-α and for Lyzs-cre versus p38γ/δLyz-KO or p38δLyz-KO mice in IL-6 (n = 6–8). (G) Liver myeloid subsets (CD11b+Gr-1hi, CD11b+Gr-1intermediate, CD11b+Gr-1–) were assessed by flow cytometry of liver leukocytes isolated from p38γLyz-KO, p38δLyz-KO, p38γ/δLyz-KO, and control Lyzs-cre transgenic mice 6 hours after injection. Representative dot plots are shown. Bar charts show each myeloid population as a percentage of the total intrahepatic leukocyte population (mean ± SD; n = 4–6). Circulating neutrophils in total blood were measured as a percentage of circulating leukocytes 4 hours after injection (n = 5–8). Data are means ± SD. **P < 0.01; ***P < 0.001 (2-way ANOVA coupled to Bonferroni’s post tests).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts